Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Lung Neoplasms 2This Study Has Been Designed to Compile Information on the Efficacy of the Partial Breast Intracavitary Brachytherapy in the Post Market Setting. 1Prostatic Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Immunoglobulin Light-chain Amyloidosis 1Adenocarcinoma 1

Interventions

Imatinib Mesylate 17Dasatinib 8nilotinib 7Cytarabine 5Hydroxyurea 4ponatinib 3Peripheral Blood Stem Cell Transplantation 3Interferon-alpha 3bosutinib 2Surveys and Questionnaires 2Stem Cell Transplantation 2Radiotherapy 2Polymerase Chain Reaction 2Pioglitazone 2Idarubicin 2Cytogenetic Analysis 2Busulfan 2Antilymphocyte Serum 2thymoglobulin 1peginterferon alfa-2a 1flumatinib 1fludarabine phosphate 1Tyrosine Kinase Inhibitors 1Therapeutics 1Registries 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1PF-114 1Mycophenolic Acid 1Mitoxantrone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Registries × Clear all
NCT00538447 2011-12-13

Prospective Database for Chronic Myelogenous Leukemia

King Faisal Specialist Hospital & Research Center

Phase NA Unknown
2,000 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡